Trident Lifeline Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003715, "name": "Trident Lifeline", "stock_name": "Trident Lifeline", "full_name": "Trident Lifeline Ltd", "name_url": "stocks-analysis/trident-lifeline", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "253.30", "chg": 7.8, "chgp": "3.18%", "dir": 1, "prev_price": "245.50", "mcapval": "311.00 Cr", "mcap": "Micro Cap", "scripcode": 543616, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0MKA01014", "curr_date": "Apr 15", "curr_time": "", "bse_nse_vol": 57000, "exc_status": "Active", "traded_date": "Apr 15, 2026", "traded_date_str": "2026 04 15", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trident-lifeline-1003715-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Trident Lifeline Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-is-rated-sell-3934153", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TridentLifeline_mojoScore_3934153.png", "date": "2026-04-06 10:10:28", "description": "Trident Lifeline Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with the latest insights into the company's performance and outlook." }, { "title": "Trident Lifeline Gains 5.52%: 2 Key Events Shaping This Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-gains-552-2-key-events-shaping-this-weeks-volatility-3921574", "imagepath": "", "date": "2026-03-28 11:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Mar:</strong> Stock edges up 0.39% despite Sensex falling 3.13%</p>\n <p><strong>24 Mar:</strong> Trident Lifeline hits 52-week low of Rs.229.95 amid market pressure</p>\n <p><strong>25 Mar:</strong> Recovery with 3.07% gain as Sensex continues upward trend</p>\n <p><strong>27 Mar:</strong> Strong 5.50% rally on valuation shift news, closing at Rs.258.80</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.245.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</..." }, { "title": "Trident Lifeline Ltd Valuation Shifts to Fair Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-valuation-shifts-to-fair-amid-mixed-market-returns-3918469", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TridentLifeline_valuationdot_3918469.png", "date": "2026-03-27 08:01:25", "description": "Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation grade shift from attractive to fair, reflecting a notable change in market perception. With a current price of ₹245.30 and a recent day gain of 3.07%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more balanced, albeit less compelling, investment case compared to its historical standing and peer group." }, { "title": "Trident Lifeline Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-is-rated-sell-by-marketsmojo-3917806", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TridentLifeline_mojoScore_3917806.png", "date": "2026-03-26 10:10:26", "description": "Trident Lifeline Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook." }, { "title": "Markets Rally, But Trident Lifeline Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-falls-to-52-week-low-of-rs22995-amid-market-pressure-3910861", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TridentLifeline_priceRelatedfactors_3910861.png", "date": "2026-03-24 15:24:08", "description": "" }, { "title": "Trident Lifeline Ltd Gains 1.85%: Valuation Shifts and Mixed Signals Shape Weekly Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-gains-185-valuation-shifts-and-mixed-signals-shape-weekly-performance-3905082", "imagepath": "", "date": "2026-03-21 11:03:28", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Mar:</strong> Stock hits 52-week low of Rs.235.1 amid mixed financial results</p>\n <p><strong>16 Mar:</strong> Valuation metrics shift to more attractive levels despite sector headwinds</p>\n <p><strong>18 Mar:</strong> Stock rallies 3.61% to Rs.246.50, outperforming Sensex gains</p>\n <p><strong>20 Mar:</strong> Week closes at Rs.245.25, up 1.85% for the week versus Sensex decline</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.240.80</div></div>\n <div class=\"stat-item\"><div cl..." }, { "title": "Trident Lifeline Ltd Falls to 52-Week Low of Rs.235.1 Amidst Mixed Financial Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-falls-to-52-week-low-of-rs2351-amidst-mixed-financial-signals-3894310", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TridentLifeline_priceRelatedfactors_3894310.png", "date": "2026-03-16 15:15:47", "description": "Trident Lifeline Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.235.1 today, marking a significant price level after a prolonged period of decline. This fresh low comes amid broader market volatility and sector-specific headwinds, reflecting a challenging phase for the micro-cap company." }, { "title": "Trident Lifeline Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-3892679", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TridentLifeline_valuationdot_3892679.png", "date": "2026-03-16 08:01:25", "description": "Trident Lifeline Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change is underscored by a significant recalibration of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap pharmaceutical and biotechnology company as a compelling consideration for investors seeking value in a volatile sector environment." }, { "title": "Trident Lifeline Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-is-rated-sell-3892046", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TridentLifeline_mojoScore_3892046.png", "date": "2026-03-15 10:10:32", "description": "Trident Lifeline Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook." } ], "total": 140, "sid": "1003715", "stock_news_url": "https://www.marketsmojo.com/news/trident-lifeline-1003715" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "08-Apr-2026", "details": "Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 as received from MUFG Intime India Private Limited (Formally known as Link Intime India Private Limited) -Companys Registrar and Share Transfer Agent for the year ended March 31 2026.", "source": "BSE" }, { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "02-Apr-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Amit Halvawala", "source": "BSE" }, { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "02-Apr-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rinkal Mayurbhai Gajera", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

23 Mar: Stock edges up 0.39% despite Sensex falling 3.13%

24 Mar: Trident Lifeline hits 52-week low of Rs.229.95 amid market pressure

25 Mar: Recovery with 3.07% gain as Sensex continues upward trend

27 Mar: Strong 5.50% rally on valuation shift news, closing at Rs.258.80

Week Open

Rs.245.25

Week CloseRead full news article

Trident Lifeline Ltd Valuation Shifts to Fair Amid Mixed Market Returns

2026-03-27 08:01:25

Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation grade shift from attractive to fair, reflecting a notable change in market perception. With a current price of ₹245.30 and a recent day gain of 3.07%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more balanced, albeit less compelling, investment case compared to its historical standing and peer group.

Read full news article

Trident Lifeline Ltd is Rated Sell by MarketsMOJO

2026-03-26 10:10:26

Trident Lifeline Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook.

Read full news article

Markets Rally, But Trident Lifeline Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-24 15:24:08

Read full news article

Trident Lifeline Ltd Gains 1.85%: Valuation Shifts and Mixed Signals Shape Weekly Performance

2026-03-21 11:03:28

Key Events This Week

16 Mar: Stock hits 52-week low of Rs.235.1 amid mixed financial results

16 Mar: Valuation metrics shift to more attractive levels despite sector headwinds

18 Mar: Stock rallies 3.61% to Rs.246.50, outperforming Sensex gains

20 Mar: Week closes at Rs.245.25, up 1.85% for the week versus Sensex decline

Week Open

Rs.240.80

Read full news article

Trident Lifeline Ltd Falls to 52-Week Low of Rs.235.1 Amidst Mixed Financial Signals

2026-03-16 15:15:47

Trident Lifeline Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.235.1 today, marking a significant price level after a prolonged period of decline. This fresh low comes amid broader market volatility and sector-specific headwinds, reflecting a challenging phase for the micro-cap company.

Read full news article

Trident Lifeline Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges

2026-03-16 08:01:25

Trident Lifeline Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change is underscored by a significant recalibration of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap pharmaceutical and biotechnology company as a compelling consideration for investors seeking value in a volatile sector environment.

Read full news article

Trident Lifeline Ltd is Rated Sell

2026-03-15 10:10:32

Trident Lifeline Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

View All News